$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
雷德帕斯的注意事项
2025-10-19 11:44:20
Check Details
Midostaurin的使用说明
2025-10-19 11:44:20
Check Details
捷报:关于急性白血病治疗的最新进展
2025-10-19 11:44:20
Check Details
关于FLT3基因突变和白血病的防治、治疗与思考
2025-10-19 11:44:20
Check Details
维奈托克有望治愈高危髓系癌患者
2025-10-19 11:44:20
Check Details
美国食品药品监督管理局(FDA)已批准维奈托克作为化疗组合药物治疗老年急性髓细胞白血病(AML)
2025-10-19 11:44:20
Check Details
案例:关于在氮杂胞苷加入维奈托克对急性髓系白血病的研究进展
2025-10-19 11:44:20
Check Details
慢性白血病患者的福音:FDA批准米哚妥林
2025-10-19 11:44:20
Check Details
关于“癌症会传染?”你不知道的真相
2025-10-19 11:44:20
Check Details
AML老年患者的治疗与思考
2025-10-19 11:44:20
Check Details
维奈托克要吃多久?
2025-10-19 11:44:20
Check Details
维奈托克 说明书
2025-10-19 11:44:20
Check Details
1
2
...
216
217
218
219
220
221
222
...
934
935
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
2
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
3
Avatrombopag (Doptelet) Dosage: Dose Adjustment and Medication Guidelines for Different Indications
4
Effects of Gilteritinib (Xospata) Discontinuation in Acute Myeloid Leukemia Treatment
5
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia
6
Kresladi Approved by FDA: First Gene Therapy for Severe LAD-I
7
Pegcetacoplan Side Effects and Medication Safety Complete Guide
8
Pegcetacoplan (Empaveli): Complete Guide to PNH Complement Inhibitor Treatment
9
Eltrombopag: Innovative TPO Receptor Agonist for Treating Thrombocytopenia - Comprehensive Drug Analysis
10
Is MDS Targeted Therapy Chemotherapy? Mechanism, Genetic Testing, and Personalized Care Guide
11
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
12
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained